Kathy Schonely

Kathy received her undergraduate degree in Biology from Eastern College (University).

She began her career as a research technician at The Wistar Institute and UCLA before moving into laboratory testing (CLIA) and Quality Control.  Kathy gained experience at several biotech startup companies – Molecular Oncology, Inc and OncorMed, before joining the QC department at Advanced Bioscience Laboratories.

Kathy gained valuable experience as the Director of Quality Control for the Virxsys Corporation, where she supported the first Phase I human clinical trial of a Lentiviral gene therapy product. In this role, Kathy was responsible for leading the QC team in qualifying methods and performing GMP lot release assays on in process and final lentiviral vector product, in addition to testing HIV-positive autologous T cell products, patient screening and monitoring samples. 

Kathy continued her focus in Lentiviral vectors when, in 2005, she joined Lentigen Technology, Inc (a Miltenyi company) as the Director of Quality Control where she oversaw tremendous growth and success during her 17 year tenure.  During this time, Kathy’s responsibilities spanned nearly every facet of QC, including assay transfer, testing of preclinical samples and GMP product release, vector stability program, and environmental monitoring.